HENRY SCHEIN INC (HSIC) Stock Price, Quote, News and Summary
NASDAQ:HSIC - Nasdaq - US8064071025 - Common Stock
HSIC Quote and Key Statistics
HENRY SCHEIN INC
NASDAQ:HSIC (1/21/2025, 3:42:07 PM)
73.975
+0.75 (+1.03%)
HSIC Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.51% | ||
| ROA | 2.96% | ||
| ROE | 8.96% | ||
| Debt/Equity | 0.73 |
HSIC Performance and Technical Analysis
HSIC Ownership and Analysts
HSIC Latest News and Analysis
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Looking for the S&P500 stocks that are experiencing notable gaps on Monday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein
/PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Acentus in the acquisition...
Henry Schein Completes Acquisition of Acentus
Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires
Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting growth and recovery potential.
About HSIC
Company Profile
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. The firm operates through two segments: health care distribution, and technology and value-added services. The health care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic products), diagnostic tests, infection-control products, personal protective equipment products and vitamins. The technology and value-added services segment provide software, technology and other value-added services to health care practitioners. The company offers dental practice management solutions for dental and medical practitioners. The company also develops solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist).
Company Info
HENRY SCHEIN INC
135 Duryea Rd
Melville NEW YORK 11747 US
CEO: Stanley M. Bergman
Employees: 26000
Company Website: https://www.henryschein.com/
Investor Relations: https://investor.henryschein.com
Phone: 16318435500
HSIC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 20.25 | 74.21B | ||
| COR | CENCORA INC | 17.76 | 47.24B | ||
| CAH | CARDINAL HEALTH INC | 16.7 | 30.79B | ||
| PDCO | PATTERSON COS INC | 14.6 | 2.73B | ||
| AHCO | ADAPTHEALTH CORP | N/A | 1.42B | ||
| OMI | OWENS & MINOR INC | 8.99 | 1.15B | ||
| AHG | AKSO HEALTH GROUP | N/A | 594.24M | ||
| COSM | COSMOS HEALTH INC | N/A | 21.63M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 9.20M | ||
| ATPC | AGAPE ATP CORP | N/A | 6.06M |